Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 93 - 101 |
| Number of pages | 9 |
| Journal | American Journal of Kidney Diseases |
| Volume | 52 |
| Issue number | 1 |
| Publication status | Published - 2008 |
Cite this
}
Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: Results of a 6-week, randomized, double-blind, crossover trial. / Pellicano, Rebecca; Polkinghorne, Kevan R; Kerr, Peter.
In: American Journal of Kidney Diseases, Vol. 52, No. 1, 2008, p. 93 - 101.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: Results of a 6-week, randomized, double-blind, crossover trial
AU - Pellicano, Rebecca
AU - Polkinghorne, Kevan R
AU - Kerr, Peter
PY - 2008
Y1 - 2008
N2 - Background: Uremic toxicity is a major concern in the dialysis population. There is keen interest in techniques that increase the removal of larger uremic molecules. We examined the short-term impact of a new, more porous, super-flux Helixone membrane (FX-E) versus the conventional high-flux Helixone
AB - Background: Uremic toxicity is a major concern in the dialysis population. There is keen interest in techniques that increase the removal of larger uremic molecules. We examined the short-term impact of a new, more porous, super-flux Helixone membrane (FX-E) versus the conventional high-flux Helixone
UR - http://www.sciencedirect.com/science/article/pii/S0272638608004666
M3 - Article
VL - 52
SP - 93
EP - 101
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
SN - 0272-6386
IS - 1
ER -